[Guidelines for the prevention and treatment of hepatitis C (2019 version)]

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Hepatitis C virus (HCV) infection remains a significant global health concern.
• The World Health Organization aims to eliminate viral hepatitis by 2030.
• Existing guidelines require updates to reflect current research and clinical practice.

Purpose of the Study:

• To standardize and update the prevention, diagnosis, and antiviral therapy for hepatitis C in China.
• To align national strategies with global hepatitis elimination goals.
• To provide evidence-based recommendations for healthcare professionals.

Main Methods:

• Revision of the national guideline for hepatitis C (2019 version).
• Involvement of native experts from the Chinese Medical Association, Chinese Society of Hepatology, and Society of Infectious Diseases.
• Consideration of domestic and international research progress in basic, clinical, and prophylactic aspects of HCV infection.
• Adaptation of recommendations to the current situation in China.

Main Results:

• A revised guideline for hepatitis C prevention and treatment (2019 version) has been developed.
• The guideline incorporates the latest advancements in hepatitis C research.
• It addresses the specific context and needs of China's healthcare system.

Conclusions:

• The updated guideline provides a crucial basis for managing hepatitis C.
• Standardized prevention, diagnosis, and treatment strategies are essential for achieving hepatitis elimination goals.
• This revision supports the national effort to combat viral hepatitis as a public health threat.